The Expression of PPAR Pathway-Related Genes Can Better Predict the Prognosis of Patients with Colon Adenocarcinoma

Figure 4

Results of PPAR-Riskscore external validation utilizing six microarray cohorts. Based on the value of PPAR-Riskscore, each cohort was separated equally into high-risk and low-risk groups. Each cohort’s Kaplan-Meier analysis and time-dependent receiver operating characteristic curves are shown.